Goldman Sachs Group Inc Relmada Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 120,852 shares of RLMD stock, worth $99,098. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120,852
Previous 120,852 -0.0%
Holding current value
$99,098
Previous $32,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$0.26 - $0.47 $31,421 - $56,800
120,852 New
120,852 $32,000
Q1 2024

May 15, 2024
BUY
$3.1 - $6.8 $366,553 - $804,052
118,243 New
118,243 $549,000
Q3 2023

May 14, 2024
BUY
$2.48 - $3.79 $32,235 - $49,262
12,998 New
12,998 $38,000
Q3 2023

Nov 14, 2023
SELL
$2.48 - $3.79 $370,385 - $566,032
-149,349 Reduced 91.99%
12,998 $38,000
Q2 2023

May 14, 2024
SELL
$2.22 - $3.54 $83,198 - $132,668
-37,477 Reduced 18.76%
162,347 $399,000
Q2 2023

Aug 14, 2023
SELL
$2.22 - $3.54 $83,198 - $132,668
-37,477 Reduced 18.76%
162,347 $399,000
Q1 2023

May 14, 2024
SELL
$2.24 - $4.76 $138,622 - $294,572
-61,885 Reduced 23.65%
199,824 $451,000
Q1 2023

May 11, 2023
SELL
$2.24 - $4.76 $138,622 - $294,572
-61,885 Reduced 23.65%
199,824 $451,000
Q4 2022

May 14, 2024
BUY
$2.17 - $35.84 $413,085 - $6.82 Million
190,362 Added 266.81%
261,709 $913,000
Q4 2022

Feb 13, 2023
BUY
$2.17 - $35.84 $413,085 - $6.82 Million
190,362 Added 266.81%
261,709 $913,000
Q3 2022

May 14, 2024
SELL
$18.3 - $37.02 $2.06 Million - $4.18 Million
-112,827 Reduced 61.26%
71,347 $2.64 Million
Q3 2022

Nov 10, 2022
SELL
$18.3 - $37.02 $2.06 Million - $4.18 Million
-112,827 Reduced 61.26%
71,347 $2.64 Million
Q2 2022

May 14, 2024
BUY
$16.5 - $30.34 $3.04 Million - $5.59 Million
184,174 New
184,174 $3.5 Million
Q2 2022

Aug 15, 2022
BUY
$16.5 - $30.34 $2.56 Million - $4.7 Million
154,883 Added 528.77%
184,174 $3.5 Million
Q1 2022

May 16, 2022
SELL
$16.72 - $26.99 $919,549 - $1.48 Million
-54,997 Reduced 65.25%
29,291 $791,000
Q4 2021

Feb 14, 2022
SELL
$16.93 - $26.82 $30,372 - $48,115
-1,794 Reduced 2.08%
84,288 $1.9 Million
Q3 2021

Nov 10, 2021
BUY
$21.86 - $34.77 $1.88 Million - $2.99 Million
86,082 New
86,082 $2.26 Million

Others Institutions Holding RLMD

# of Institutions
49
Shares Held
6.3M
Call Options Held
0
Put Options Held
0
View Full List

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $23.5M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email